GLP-1 medications are not recommended during pregnancy, have a history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 and/or are allergic to any of the ingredients in the medication
doi: 10.3389/fimmu.2021.714177 7 KimWEganJM
It did stress the importance of reporting suspected side effects and adverse incidents to the Yellow Card scheme, adding that it "engages regularly with the MHRA and disseminates information on drug safety to healthcare professionals, including recent MHRA guidance on the safe use of GLP-1 medicines"
Practice Expertise & Credentials: Board-certified plastic surgeons directing medical care Over 35 years of combined surgical and aesthetic expertise Highly rated by patients Two convenient Orange County locations (Newport Beach and Orange) Virtual and in-person consultations available Personalized treatment plans tailored to your unique health profile Convenient at-home medication delivery to California addresses Comprehensive support throughout your weight loss journey Understanding Semaglutide & Tirzepatide Semaglutide and tirzepatide are FDA-approved GLP-1 receptor agonist medications designed to support sustainable weight loss
(accessed June 2022) 19Bain S
Effects of Once-Weekly Semaglutide on Appetite, Energy Intake, Control of Eating, Food Preference and Body Weight in Subjects With Obesity